News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,632 Results
Type
Article (18370)
Company Profile (153)
Press Release (204109)
Section
Business (61735)
Career Advice (197)
Deals (8994)
Drug Delivery (58)
Drug Development (33976)
Employer Resources (33)
FDA (6756)
Job Trends (6250)
News (112153)
Policy (11326)
Tag
2024 BioCapital Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1580)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (41)
Alliances (17760)
ALS (41)
Alzheimer's disease (578)
Antibody-drug conjugate (ADC) (39)
Approvals (6813)
Artificial intelligence (128)
Autoimmune disease (9)
Automation (6)
Bankruptcy (55)
Best Places to Work (5991)
BIOSECURE Act (6)
Biosimilars (59)
Biotechnology (112)
Bladder cancer (34)
Brain cancer (13)
Breast cancer (129)
Cancer (1012)
Cardiovascular disease (102)
Career advice (175)
Career pathing (6)
CAR-T (73)
Cell therapy (209)
Cervical cancer (9)
Clinical research (28265)
Collaboration (426)
Compensation (176)
Complete response letters (8)
COVID-19 (1080)
CRISPR (31)
C-suite (118)
Cystic fibrosis (58)
Data (1173)
Decentralized trials (1)
Denatured (13)
Depression (17)
Diabetes (143)
Diagnostics (2219)
Digital health (8)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (67)
Drug pricing (57)
Drug shortages (17)
Duchenne muscular dystrophy (52)
Earnings (18813)
Editorial (12)
Employer branding (2)
Employer resources (31)
Events (32997)
Executive appointments (333)
FDA (7370)
Featured Employer (31)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (294)
Gene editing (75)
Generative AI (14)
Gene therapy (176)
GLP-1 (388)
Government (1588)
Grass and pollen (1)
Guidances (23)
Healthcare (7644)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (43)
Indications (19)
Infectious disease (1149)
Inflammatory bowel disease (93)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (35)
Interviews (14)
IPO (4334)
IRA (21)
Job creations (719)
Job search strategy (167)
Kidney cancer (6)
Labor market (7)
Layoffs (127)
Leadership (2)
Legal (1794)
Liver cancer (29)
Lung cancer (153)
Lymphoma (88)
Machine learning (3)
Management (10)
Manufacturing (124)
MASH (36)
Medical device (2568)
Medtech (2569)
Mergers & acquisitions (4866)
Metabolic disorders (375)
Multiple sclerosis (33)
NASH (12)
Neurodegenerative disease (34)
Neuropsychiatric disorders (8)
Neuroscience (825)
NextGen: Class of 2025 (2128)
Non-profit (1695)
Northern California (1161)
Now hiring (7)
Obesity (213)
Opinion (72)
Ovarian cancer (38)
Pain (49)
Pancreatic cancer (25)
Parkinson's disease (59)
Partnered (10)
Patents (74)
Patient recruitment (42)
Peanut (23)
People (22265)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase I (7848)
Phase II (11430)
Phase III (11072)
Pipeline (516)
Podcasts (28)
Policy (57)
Postmarket research (1436)
Preclinical (3080)
Press Release (15)
Prostate cancer (50)
Psychedelics (9)
Radiopharmaceuticals (142)
Rare diseases (216)
Real estate (1538)
Recruiting (9)
Regulatory (8980)
Reports (12)
Research institute (1347)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (3)
RSV (17)
Schizophrenia (35)
Series A (63)
Series B (44)
Service/supplier (1)
Sickle cell disease (38)
Southern California (896)
Special edition (6)
Spinal muscular atrophy (84)
Sponsored (10)
Startups (1356)
Stomach cancer (6)
Supply chain (32)
Tariffs (6)
The Weekly (14)
United States (9410)
Vaccines (282)
Venture capitalists (16)
Webinars (3)
Weight loss (129)
Women's health (13)
Worklife (1)
Date
Today (54)
Last 7 days (253)
Last 30 days (1199)
Last 365 days (15035)
2025 (3908)
2024 (15468)
2023 (16756)
2022 (20917)
2021 (21715)
2020 (19864)
2019 (17100)
2018 (12831)
2017 (12035)
2016 (11195)
2015 (12067)
2014 (8452)
2013 (6942)
2012 (7035)
2011 (7000)
2010 (5671)
Location
Africa (236)
Alabama (24)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (15011)
Australia (2085)
California (2458)
Canada (616)
China (250)
Colorado (81)
Connecticut (134)
Delaware (92)
Europe (33508)
Florida (350)
Georgia (65)
Idaho (14)
Illinois (222)
India (16)
Indiana (169)
Iowa (3)
Japan (111)
Kansas (35)
Kentucky (7)
Louisiana (4)
Maine (26)
Maryland (277)
Massachusetts (2119)
Michigan (32)
Minnesota (70)
Mississippi (1)
Missouri (37)
Montana (7)
Nebraska (4)
Nevada (10)
New Hampshire (10)
New Jersey (912)
New Mexico (10)
New York (721)
North Carolina (425)
North Dakota (5)
Northern California (1161)
Ohio (74)
Oklahoma (4)
Oregon (17)
Pennsylvania (510)
Puerto Rico (1)
Rhode Island (8)
South America (296)
South Carolina (3)
Southern California (896)
Tennessee (24)
Texas (260)
Utah (86)
Virginia (59)
Washington D.C. (34)
Washington State (254)
Wisconsin (23)
222,632 Results for "scipher medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scipher Medicine and Roivant Partner to Bring Precision Medicine Insights to Rheumatology Drug Discovery and Development
January 13, 2025
·
2 min read
Press Releases
Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network
December 18, 2024
·
3 min read
Press Releases
OMNY Health and Scipher Medicine Partner to Revolutionize Autoimmune Disease Treatment with Clinico-Transcriptomics Data
January 9, 2025
·
4 min read
Business
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine’s Next Phase of Growth
Scipher Medicine, an AI-enabled precision immunology company, today announced the appointment of Reginald Seeto, MBBS*, as Chief Executive Officer and President.
May 9, 2024
·
5 min read
Business
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
Quest Diagnostics and Scipher Medicine, today announced a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).
November 28, 2023
·
6 min read
Business
Scipher Medicine Signs Multi-Target Partnership with Ionis
Scipher Medicine announced that it has entered into a multi-disease area collaboration with Ionis Pharmaceuticals.
July 17, 2023
·
2 min read
Genetown
Scipher Medicine Receives Medicare Coverage for PrismRA® Test in Rheumatoid Arthritis Patients
Scipher Medicine Corporation today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), and Centers for Medicare and Medicaid Services (CMS) published a local coverage determination (LCD) for molecular biomarker testing to guide targeted therapy selection in rheumatoid arthritis (RA) patients.
September 7, 2023
·
2 min read
Genetown
Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
Scipher Medicine announced data validating the clinical utility of the company’s PrismRA test for guiding treatment selection for rheumatoid arthritis (RA) patients.
November 10, 2022
·
3 min read
Genetown
Galapagos In-licenses Novel Drug Targets for Inflammatory Bowel Disease Discovered by Scipher Medicine’s Spectra™ Platform
Scipher Medicine today announced that Galapagos (Euronext & NASDAQ: GLPG) has exercised its option to in-license novel drug targets for inflammatory bowel disease (IBD) discovered by Scipher’s Spectra™ platform.
May 24, 2022
·
2 min read
Business
TARA Biosystems Partners with Scipher Medicine®
TARA Biosystems Partners with Scipher Medicine ®
November 3, 2021
·
5 min read
1 of 22,264
Next
